Trademarkia Logo

United Kingdom

£
Trademark Search
ONCOLYTIC IMMUNOTHERAPY

View On IPO.GOV.UK

Registered

on 19 Dec 2024

Last Applicant/ Owned by

CG Oncology, Inc.

400 Spectrum Center Dr., Suite 2040, Irvine

California 92618, ,

Serial Number

UK00004139302 filed on 19th Dec 2024

Registration Number

UK00004139302 registered on
21st Mar 2025

Correspondent Information

Kilburn & Strode LLP

Lacon London, 84 Theobalds Road, Holborn

London,

WC1X 8NL

ONCOLYTIC IMMUNOTHERAPY

pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunolog Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceutical products for the treatment of cancer; pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing.

Class [42]
Computer & Software Services & Scientific Services

Pharmaceutical research and development; Providing medical and scientific research information in the fields of oncology, autoimmune disorders, immunotherapy, immunotherapeutics, biotechnology, biopharmaceuticals, pharmaceuticals, therapies, diseases, and disorders.

Mark Details

Serial Number

UK00004139302

Mark Type

Figurative

Kind of mark

Individual